3.35  -0.23 (-6.42%)		08-06 16:00
Open: 3.26 High: 3.4 Volume: 21,551		Pre. Close: 3.58 Low: 3.057 Market Cap: 9(M)

Short term
Mid term
Targets	6-month :	5.42	1-year :	6.97
Resists	First :	4.64	Second :	5.96
Pivot price	3.33
Supports	First :	2.5	Second :	2.07
MAs	MA(5) :	3.14	MA(20) :	3.58
	MA(100) :	3.25	MA(250) :	6.04
MACD	MACD :	-0.4	Signal :	-0.3
%K %D	K(14,3) :	24.4	D(3) :	19
RSI	RSI(14): 46
52-week	High :	76	Low :	1.75

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CUPR ] has closed below upper band by 49.2%. Bollinger Bands are 36% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	3.4 - 3.42	3.42 - 3.44
Low:	3.02 - 3.04	3.04 - 3.05
Close:	3.32 - 3.35	3.35 - 3.38

Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.

Wed, 24 Jun 2026
Why Leifras Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket - Benzinga

Tue, 16 Jun 2026
These stocks are gapping in today's session - ChartMill

Fri, 12 Jun 2026
Cuprina regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada

Fri, 12 Jun 2026
Cuprina Holdings Regains Compliance with Nasdaq Capital Markets Listing Requirements | CUPR Stock News - Quiver Quantitative

Fri, 22 May 2026
Cuprina plans 1-for-8 reverse stock split to meet Nasdaq rules - Investing.com

Wed, 15 Apr 2026
Rosen Law Firm Encourages Cuprina Holdings (Cayman) Ltd. Investors to Inquire About Securities Class Action Investigation – CUPR - Business Wire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	-6 (M)
Shares Float	0 (M)
Held by Insiders	920620 (%)
Held by Institutions	920630 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	-645
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-1.41
Profit Margin	0 %
Operating Margin	-10 %
Return on Assets (ttm)	568.3 %
Return on Equity (ttm)	-59 %
Qtrly Rev. Growth	569 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	-4.79e+006 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	-2.38
Price to Sales	0
Price to Cash Flow	0

Dividend	3570
Forward Dividend	222530
Dividend Yield	106567%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.